Icrucumab Biosimilar - Anti-VEGF Receptor 1 Antibody - BSA and Azide free (A338821)

Icrucumab Biosimilar - Anti-VEGF Receptor 1 Antibody - BSA and Azide free

Recombinant human monoclonal antibody to VEGF Receptor 1 for use as a research grade Icrucumab biosimilar.

ELISA, Flow Cytometry, Functional Studies, in vivo Research

Human

Human

Monoclonal

IgG1

Liquid

Supplied in 0.01M Phosphate Buffered Saline, pH 7.4.

Shipped at 4°C. Upon delivery store at 4°C for short-term use (1-2 weeks) or aliquot and store at -20°C for long-term use (up to 12 months).

FLT, FLT-1, FLT1, Fms-like tyrosine kinase 1, FRT, Tyrosine-protein kinase FRT, Tyrosine-protein kinase receptor FLT, Vascular endothelial growth factor receptor 1, Vascular permeability factor receptor, VEGFR-1, VEGFR1